CAS 21770-81-0|1-Methylguanidine hydrochloride
| Common Name | 1-Methylguanidine hydrochloride | ||
|---|---|---|---|
| CAS Number | 21770-81-0 | Molecular Weight | 109.55800 |
| Density | 1.22 g/mL at 20 °C(lit.) | Boiling Point | 72 °C |
| Molecular Formula | C2H8ClN3 | Melting Point | -20 °C |
| MSDS | ChineseUSA | Flash Point | 65 °F |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | 2-methylguanidine,hydrochloride |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.22 g/mL at 20 °C(lit.) |
|---|---|
| Boiling Point | 72 °C |
| Melting Point | -20 °C |
| Molecular Formula | C2H8ClN3 |
| Molecular Weight | 109.55800 |
| Flash Point | 65 °F |
| Exact Mass | 109.04100 |
| PSA | 61.90000 |
| LogP | 1.09220 |
| Index of Refraction | n20/D 1.4279(lit.) |
| Water Solubility | insoluble |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LDLo - Lowest published lethal dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 375 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 28,251,1926
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 680 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CKFRAY Ceskoslovenska Farmacie. (PNS-Ustredni Expedice a Dovoz Tisku, Kafkova 19, 160 00 Prague 6, Czechoslovakia) V.1- 1952- Volume(issue)/page/year: 1,434,1952
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 18 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- CSLNX* U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. (Aberdeen Proving Ground, MD 21010) Volume(issue)/page/year: NX#04013
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H315-H319 |
| Precautionary Statements | P280-P301 + P312 + P330-P305 + P351 + P338-P337 + P313 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xn: Harmful; |
| Risk Phrases | R22 |
| Safety Phrases | S26-S36/37 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | MF3990000 |
Preparation
Articles4
More Articles| Organic anion transporting polypeptides 1B1 and 1B3 play an important role in uremic toxin handling and drug-uremic toxin interactions in the liver. J. Pharm. Pharm. Sci. 17(4) , 475-84, (2015) Organic anion-transporting polypeptide (OATP) 1B1 and OATP1B3 contribute to hepatic uptake of numerous drugs. Thus, reduced OATP1B1 and OATP1B3 activity in chronic kidney disease (CKD) may have a majo... | |
| Structure and dynamics of a salt-bridge model system in water and DMSO. J. Chem. Phys. 142 , 212436, (2015) We study the interaction between the ions methylguanidinium and trifluoroacetate dissolved in D2O and dimethylsulfoxide with linear infrared spectroscopy and femtosecond two-dimensional infrared spect... | |
| In-vitro evidence of enhanced breast cancer resistance protein-mediated intestinal urate secretion by uremic toxins in Caco-2 cells. J. Pharm. Pharmacol. 67(2) , 170-7, (2015) It has been reported that intestinal urate excretion is increased at chronic kidney disease (CKD) state. In this report, whether uremic toxins are involved in the upregulation of intestinal breast can... |
Synonyms
| 1-Methylguanidine hydrochloride |
| 1-Methylguanidine HCl |
| 2-methylguanidine hydrochloride |
| Methylguanidine HCl |
| Methylguanidinehydrochloride |
| MFCD00012576 |
